How many employees does Kezar Life Sciences have this year?
Kezar Life Sciences has 47 undefined employees this year.
In 2024, Kezar Life Sciences employed 47 people, a 0% change from the 47 number of employees in the previous year.
Kezar Life Sciences's employees are a pivotal aspect of its operations, driving innovation, productivity, and growth. The size and composition of the workforce offer insights into the company's scale, diversity, and investment in human capital. Analyzing employee trends and data is essential for understanding Kezar Life Sciences's operational capacity and future potential.
Assessing Kezar Life Sciences's employee numbers year-over-year helps in identifying growth patterns, expansions, or contractions. An increasing employee count can indicate scaling operations and investment in talent, while a decrease may signal efficiency improvements, automation, or business challenges.
Kezar Life Sciences's employee data impacts investment decisions by shedding light on the company’s operational efficiency, innovation capability, and sustainability. Investors assess workforce data to gauge the firm's potential to execute strategies, innovate, and adapt to market changes effectively.
Fluctuations in Kezar Life Sciences’s employee numbers indicate changes in business strategy, operational demands, and market dynamics. Investors and analysts scrutinize these trends to evaluate the company’s strategic positioning, adaptability, and potential for sustainable growth.
Kezar Life Sciences has 47 undefined employees this year.
Compared to the previous year, Kezar Life Sciences had 0% more employees.
The number of employees has a direct impact on the efficiency and productivity of Kezar Life Sciences. A higher number of employees can indicate that the company is growing and has more resources to achieve its goals, while a lower number of employees may suggest that the company is saving costs or facing difficulties in recruiting new employees.
The number of employees can also have an impact on investors of Kezar Life Sciences, as it can be an indicator of the company's growth and financial health. A higher number of employees can promise investors, while a lower number of employees may raise concerns.
An increase in equity of Kezar Life Sciences can improve the financial strength of the company and increase its ability to make future investments and fulfill obligations.
A reduction in equity of Kezar Life Sciences can impair its financial stability and decrease its ability to fulfill future investments and obligations.
Some factors that can influence the equity of Kezar Life Sciences include, among others, revenue development, profit and loss statement, dividend payments, and investments.
The equity of Kezar Life Sciences is important for investors as it is an indicator of the company's financial stability and provides investors with information on the amount of financial backing the company has in terms of obligations and future investments.
The number of employees at Kezar Life Sciences can directly impact the growth and performance of the company. A higher number of employees can lead to increased capacity and productivity, while a lower number of employees may result in reduced efficiency and limitations.
In recent years, the number of employees at Kezar Life Sciences has changed by 0.
Kezar Life Sciences currently has 47 undefined employees.
The number of employees is important for investors of Kezar Life Sciences as it is an indicator of the growth potential and performance of the company. It also provides information on how the company is able to manage and recruit its workforce.
To change the number of employees, Kezar Life Sciences can take various measures such as adjusting compensation packages, improving working conditions, conducting recruitment campaigns, and promoting a positive corporate culture. It is important for the company to conduct a thorough assessment of its situation to determine the best strategic actions to change its number of employees.
Over the past 12 months, Kezar Life Sciences paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Kezar Life Sciences is expected to pay a dividend of 0 USD.
The current dividend yield of Kezar Life Sciences is .
Kezar Life Sciences pays a quarterly dividend. This is distributed in the months of .
Kezar Life Sciences paid dividends every year for the past 0 years.
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
Kezar Life Sciences is assigned to the 'Health' sector.
To receive the latest dividend of Kezar Life Sciences from 11/1/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 11/1/2024.
The last dividend was paid out on 11/1/2024.
In the year 2023, Kezar Life Sciences distributed 0 USD as dividends.
The dividends of Kezar Life Sciences are distributed in USD.
The Kezar Life Sciences stock can be added to a savings plan with the following providers: Trade Republic
Our stock analysis for Kezar Life Sciences Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Kezar Life Sciences Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.